1691249-44-1 ((R)-Zanubrutinib,(R)-Zanubrutinib)

赞布替尼杂质;(R)-赞鲁替尼;(R)-赞布替尼;赞布替尼杂质系列;R-泽布替尼;化合物 T13447;

(R)-Zanubrutinib;(R)-BGB-3111;Pyrazolo[1,5-a]pyrimidine-3-carboxamide, 4,5,6,7-tetrahydro-7-[1-(1-oxo-2-propen-1-yl)-4-piperidinyl]-2-(4-phenoxyphenyl)-, (7R)-;Zanubrutinib Impurity 1 ((R)-Zanubrutinib);MS-28722;BZ170196;E77326;(R)-BGB-3111; (R)-BGB 3111; (R)-BGB3111;CHEMBL4107402;US9447106, 27a (peak 1);J5UMF98KEY;(7R)-4,5,6,7-Tetrahydro-7-[1-(1-oxo-2-propen-1-yl)-4-piperidinyl]-2-(4-phenoxyphenyl)pyrazolo[1,5-a]pyrimidine-3-carboxamide;(S)-Zanubrutinib;SCHEMBL22159617;Zanubrutinib, (R)-;BCP30082;SCHEMBL18090709;AKOS040740645;BDBM250081;(7R)-2-(4-phenoxyphenyl)-7-[1-(prop-2-enoyl)piperidin-4-yl]-4H,5H,6H,7H-pyrazolo[1,5-a]pyrimidine-3-carboxamide;1691249-44-1;CS-0021870;(7R)-2-(4-phenoxyphenyl)-7-(1-prop-2-enoylpiperidin-4-yl)-4,5,6,7-tetrahydropyrazolo[1,5-a]pyrimidine-3-carboxamide;DA-59625;HY-101474B;EX-A3705;

MFCD31567462

RNOAOAWBMHREKO-JOCHJYFZSA-N

1S/C27H29N5O3/c1-2-23(33)31-16-13-18(14-17-31)22-12-15-29-27-24(26(28)34)25(30-32(22)27)19-8-10-21(11-9-19)35-20-6-4-3-5-7-20/h2-11,18,22,29H,1,12-17H2,(H2,28,34)/t22-/m1/s1

C12=C(C(N)=O)C(C3=CC=C(OC4=CC=CC=C4)C=C3)=NN1[C@@H](C1CCN(C(=O)C=C)CC1)CCN2